patent/EP-2251013-A3

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2251013-A3

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_150846022f9e7f3a38831ad9d97f165e
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-66 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-65746 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L9-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-66 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N57-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate	2007-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a1eea7e8302c8231630014df3685569 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d42041a2ad67aa1bf8abc2c7396036e4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3144c6ca2fee1934a988f4daca87d08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9fe09b1887ca1255f40158784eff89dd
publicationDate	2011-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	EP-2251013-A3
titleOfInvention	Use of inositol-tripyrophosphate in treating Alzheimer's disease, stroke or osteoporosis
abstract	Inositol-tripyrophosphate is an allosteric effector of hemoglobin due to its ability to cross the plasma membrane of red blood cells and deliver oxygen to solid tumours, by lowering the oxygen affinity of the hemoglobin of red blood cells. The present invention is directed to the use of inositol-tripyrophosphate to reduce hemoglobin's affinity for oxygen in circulating red blood cells. The present invention is further directed to the use of inositol-tripyrophosphate for the treatment of Alzheimer's disease, stroke and osteoporosis.
priorityDate	2006-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4847082-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006102060-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03092700-A1
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226573054 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID246867790 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22016588 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID977 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523291

Total number of triples: 46.